Question 1

What is the catalog number for TRAF3IP2 Immunizing Peptide?

Accepted Answer

The catalog number for TRAF3IP2 Immunizing Peptide is MBS427968.

Question 2

What sizes are available for TRAF3IP2 Immunizing Peptide?

Accepted Answer

TRAF3IP2 Immunizing Peptide is available in the following size(s): 0.1 mg, 5x 0.1 mg.

Question 3

How many pack sizes does TRAF3IP2 Immunizing Peptide come in?

Accepted Answer

TRAF3IP2 Immunizing Peptide is available in 2 different pack sizes.

Question 4

Is TRAF3IP2 Immunizing Peptide in stock?

Accepted Answer

TRAF3IP2 Immunizing Peptide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 6

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 7

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

TRAF3IP2 Immunizing Peptide

Product Specifications

Gene Name

NCBI Gene ID

Reactivity

Storage Conditions

Other Gene Names

Short Name

Other Product Names

NCBI GI Number

NCBI Accession Number

NCBI GB Accession Number

Available Sizes

Frequently Asked Questions

Explore Other Products

CDKN2A/p16-INK4a Rabbit Polyclonal Antibody (Cy7)

Rabbit Polyclonal BAF180/PB1 Antibody [DyLight 488]

Recombinant Human SOSTDC1 Protein, N-His

Recombinant Human SOSTDC1 Protein, N-His

Recombinant Human SOSTDC1 Protein, N-His

Interleukin 2 (IL-2) (MaxLight 490) discontinued